Cargando…
The role of aspirin in the prevention of ovarian, endometrial and cervical cancers
Drug repurposing is the application of an existing licenced drug for a new indication and potentially provides a faster and cheaper approach to developing new anti-cancer agents. Gynaecological cancers contribute significantly to the global cancer burden, highlighting the need for low cost, widely a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543116/ https://www.ncbi.nlm.nih.gov/pubmed/33019903 http://dx.doi.org/10.1177/1745506520961710 |
_version_ | 1783591671074652160 |
---|---|
author | Joharatnam-Hogan, Nalinie Cafferty, Fay H Macnair, Archie Ring, Alistair Langley, Ruth E |
author_facet | Joharatnam-Hogan, Nalinie Cafferty, Fay H Macnair, Archie Ring, Alistair Langley, Ruth E |
author_sort | Joharatnam-Hogan, Nalinie |
collection | PubMed |
description | Drug repurposing is the application of an existing licenced drug for a new indication and potentially provides a faster and cheaper approach to developing new anti-cancer agents. Gynaecological cancers contribute significantly to the global cancer burden, highlighting the need for low cost, widely accessible therapies. A large body of evidence supports the role of aspirin as an anti-cancer agent, and a number of randomized trials are currently underway aiming to assess the potential benefit of aspirin in the treatment of cancer. This review summarizes the evidence underpinning aspirin use for the prevention of the development and recurrence of gynaecological cancers (ovarian, endometrial and cervical) and potential mechanisms of action. |
format | Online Article Text |
id | pubmed-7543116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-75431162020-10-20 The role of aspirin in the prevention of ovarian, endometrial and cervical cancers Joharatnam-Hogan, Nalinie Cafferty, Fay H Macnair, Archie Ring, Alistair Langley, Ruth E Womens Health (Lond) Review Drug repurposing is the application of an existing licenced drug for a new indication and potentially provides a faster and cheaper approach to developing new anti-cancer agents. Gynaecological cancers contribute significantly to the global cancer burden, highlighting the need for low cost, widely accessible therapies. A large body of evidence supports the role of aspirin as an anti-cancer agent, and a number of randomized trials are currently underway aiming to assess the potential benefit of aspirin in the treatment of cancer. This review summarizes the evidence underpinning aspirin use for the prevention of the development and recurrence of gynaecological cancers (ovarian, endometrial and cervical) and potential mechanisms of action. SAGE Publications 2020-10-05 /pmc/articles/PMC7543116/ /pubmed/33019903 http://dx.doi.org/10.1177/1745506520961710 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Joharatnam-Hogan, Nalinie Cafferty, Fay H Macnair, Archie Ring, Alistair Langley, Ruth E The role of aspirin in the prevention of ovarian, endometrial and cervical cancers |
title | The role of aspirin in the prevention of ovarian, endometrial and cervical cancers |
title_full | The role of aspirin in the prevention of ovarian, endometrial and cervical cancers |
title_fullStr | The role of aspirin in the prevention of ovarian, endometrial and cervical cancers |
title_full_unstemmed | The role of aspirin in the prevention of ovarian, endometrial and cervical cancers |
title_short | The role of aspirin in the prevention of ovarian, endometrial and cervical cancers |
title_sort | role of aspirin in the prevention of ovarian, endometrial and cervical cancers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543116/ https://www.ncbi.nlm.nih.gov/pubmed/33019903 http://dx.doi.org/10.1177/1745506520961710 |
work_keys_str_mv | AT joharatnamhogannalinie theroleofaspirininthepreventionofovarianendometrialandcervicalcancers AT caffertyfayh theroleofaspirininthepreventionofovarianendometrialandcervicalcancers AT macnairarchie theroleofaspirininthepreventionofovarianendometrialandcervicalcancers AT ringalistair theroleofaspirininthepreventionofovarianendometrialandcervicalcancers AT langleyruthe theroleofaspirininthepreventionofovarianendometrialandcervicalcancers AT joharatnamhogannalinie roleofaspirininthepreventionofovarianendometrialandcervicalcancers AT caffertyfayh roleofaspirininthepreventionofovarianendometrialandcervicalcancers AT macnairarchie roleofaspirininthepreventionofovarianendometrialandcervicalcancers AT ringalistair roleofaspirininthepreventionofovarianendometrialandcervicalcancers AT langleyruthe roleofaspirininthepreventionofovarianendometrialandcervicalcancers |